cytarabine has been researched along with mk-1775 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buck, SA; Caldwell, JT; Edwards, H; Ge, Y; Taub, JW | 1 |
| Baturin, D; Burleson, TM; Ford, JB; Kim, YM; Porter, CC; Van Linden, AA | 1 |
| Fosmire, SP; Garcia, TB; Porter, CC | 1 |
| Chorna, N; Diaz-Quiñones, AO; Maldonado, HM; Ortiz, WIS; Rodríguez-Vázquez, GO; Salgado-Villanueva, IK; Tang, J | 1 |
4 other study(ies) available for cytarabine and mk-1775
| Article | Year |
|---|---|
Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; Cytarabine; Down Syndrome; Drug Synergism; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Nuclear Proteins; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Reverse Transcriptase Polymerase Chain Reaction | 2014 |
AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cytarabine; DNA Repair; Drug Synergism; Female; Flow Cytometry; Humans; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Pyrimidinones; Xenograft Model Antitumor Assays | 2015 |
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cytarabine; DNA Damage; Drug Resistance, Neoplasm; Humans; Nuclear Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones | 2018 |
Synergistic interactions of cytarabine-adavosertib in leukemic cell lines proliferation and metabolomic endpoints.
Topics: Cell Line; Cell Proliferation; Cytarabine; Humans; Leukemia; Leukocytes, Mononuclear | 2023 |